ArchiMed is a global investment firm specializing in the healthcare sector, supporting small to midsize companies with investments ranging from 10 million to 1 billion euros. The firm focuses on growth and business development, leveraging its expertise in internationalization, innovation, and acquisitions to accelerate company performance and contribute to improved health outcomes.
Recent Transactions involving ArchiMed
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Bird & Bird Advises ArchiMed in Three Acquisitions |
ImaBiotechPyxant Labs |
ArchiMed |
Bioanalytical Services Bioanalytical Laboratory Services | |
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →